Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Silo Pharma, Inc. - Common Stock (OP: SILO )

N/A UNCHANGED
Last Price Updated: 3:23 PM EDT, Sep 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Silo Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >
San Francisco Passes Resolution to Decriminalize Psilocybin Mushrooms
Via Investor Brand Network
Study Finds Depression Symptoms in Partners Caring for Dementia Patients May Start Long Before Cognitive Decline
Via Investor Brand Network
Georgia Legislators Discuss Psychedelics for Veterans During Committee Hearing
Via Investor Brand Network
New Research Finds Link Between Psychedelic-Induced Mystical Experiences and EcoFriendly Behavior
Via Investor Brand Network
Research Indicates Better Sleep Efficiency Benefits Fibromyalgia Sufferers
Via Investor Brand Network
Silo Pharma Inc. (SILO): Promising Psylocibin Study Ongoing with UCSF
Via Investor Brand Network
Important Factors to Consider When Designing Psychedelic Clinical Trial Protocols
Via Investor Brand Network
Psychedelics Company Raises More than $10M in Seed Funding to Advance Ketamine Therapy
Via Investor Brand Network
Study Explains How Threatening Cues Are Refined into Fear Signals
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Fusing Traditional Therapeutics with Psychedelic Research
Via Investor Brand Network
Study Finds More Than 5.5 Million Adults in the US Use Hallucinogens
Via Investor Brand Network
California Senator Sees New Path to Get Psychedelics Decriminalization Bill Approved
Via Investor Brand Network
Study Finds Vitamin D May Help Alleviate Depression Symptoms
Via Investor Brand Network
Psychedelics Advocates Put DEA Under Pressure Over Right to Try Laws
Via Investor Brand Network
Second Psychedelics Initiative Fails to Qualify for Colorado Ballot
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc.’s (SILO) Ketamine Study Generates ‘Extremely Promising’ Data
Via Investor Brand Network
Study Finds Smells Experienced in Nature Boost Mental Health
Via Investor Brand Network
Leading Neuroscientist Explains How Psychedelics Alters the Brain
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Research on Novel Liposomes
Via Investor Brand Network
Three Clinical Trials On Psychedelic Microdosing Worth Following
Via Investor Brand Network
Silo Pharma Inc.’s (SILO) Ketamine Study Produces Positive Endpoint Results, Suggests Topical Formulation Reduces Neuropathic Nerve Pain
Via Investor Brand Network
Research Finds That Tourism, Travel May Boost Mental Health
Via Investor Brand Network
The DEA Rescinds Proposal to Ban Five Psychedelics
Via Investor Brand Network
Measure to Legalize Psychedelics Qualifies for November Ballot in Colorado
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Study Evaluating Topically Administered Ketamine Formulation
Via Investor Brand Network
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam... 
Via FinancialNewsMedia
Topics Law Enforcement
Exposures Legal
Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine
From Silo Pharma, Inc.
Via GlobeNewswire
Study Highlights Concerns on Police Involvement in Emergency Mental Health Transfers
Via Investor Brand Network
Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO), UMB Collaborating on Potentially Significant Homing-Peptide Technology
Via Investor Brand Network
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.